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Introduction
Whilst some individuals progress through life and maintain 
relatively high levels of cognitive function, for most, some 
form of cognitive decline in later life is expected. Such 
changes vary among aging individuals but they may include 
some slowing of reaction time, a decrease in the capacity for 
memory and a reduction in visuospatial ability.1 Importantly, 
however, for this majority of older individuals who experience 
some alteration in neurocognitive functioning, the change is 
mild and not sufficiently powerful to dissolve their capacity 
for normal social and occupational functioning. In contrast, 
the dramatic decline that results from dementia sees a 
global loss of normal cognitive function. This article outlines 
suggestions for the effective assessment and management 
of dementia for general family practitioners.
Dementia in South Africa
The aging segment of the population is expanding 
worldwide; South Africa, in particular, has one of the most 
rapidly aging populations in Africa.2 A substantial increase 
in the proportion of aging individuals who are likely to 
develop dementia can consequently be expected over 
the next 40 years. More than 30 million people worldwide 
are currently living with dementia. This figure, however, 
is expected to rise to 100 million by the year 2050, when 
more than 1 in 5 individuals will be over the age of 60.3 This 
worldwide phenomenon sees an exponential growth in the 
over-65 age category, whilst lowered fertility rates and high 
rates of infant mortality will most likely render South Africa 
especially affected.
Additionally, cognitive impairment and later dementia are 
a common associated symptom of the AIDS stage of HIV 
disease. Many studies have found moderate to severe 
cognitive deficits in the majority of HIV-positive individuals 
sampled.4 Sub-Saharan Africa remains the region most 
heavily affected by HIV worldwide, accounting for over two-
thirds (67%) of all people living with HIV and for nearly three-
quarters (72%) of AIDS-related deaths in 2008.5 Given this 
increasingly high prevalence of HIV illness, it is expected 
that South African physicians will most likely encounter 
similarly rising rates of dementing disease and the full 
spectrum of HIV-related neuropsychiatric symptoms.
Diagnosis of dementia
Early identification
Family practitioners are often the first port of call for families 
seeking advice regarding a family member’s suspected 
dementia. Although the full diagnostic criteria for dementia 
may not yet be warranted at this early stage, the diagnostic 
label of ‘mild cognitive impairment’ (MCI) may be used for 
those individuals who evidence objective and subjective 
memory difficulties (preferably corroborated by a collateral 
source) in the presence of normal general cognitive 
functioning and the intact activities of daily living but who 
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Abstract
South African family practitioners can expect to contend with rising rates of dementia as the aged segment of the population 
grows larger and HIV-related neuropsychiatric complications manifest with increasing prevalence. Family practitioners are 
often the first professional consulted by families concerned with a family member’s suspected dementia. This fortunate 
position facilitates the early identification of cognitive difficulties, which, in turn, greatly increases the likelihood of optimal 
management. Dementia is best managed with a multidisciplinary-team approach that sees family practitioners fulfilling the 
role of key support to families and of the coordinators of multidisciplinary referrals and inputs. This article reviews the key 
diagnostic features of dementia and provides suggestions that may be utilised by physicians in the basic assessment of 
these features. It concludes with a summary of the most appropriate management plan to be adopted by family practitioners.
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are not yet demented. It appears, however, that patients 
with MCI are at increased risk of the later development 
of Alzheimer’s disease (AD).6 The early detection of MCI 
is therefore imperative in delaying this seemingly natural 
progression towards the development of AD and it is family 
practitioners who may be in the best position to facilitate 
this early response.
Diagnostic criteria
The essential feature of a dementia is the development 
of multiple cognitive deficits that include memory 
impairment and at least one of the following cognitive 
disturbances: aphasia, apraxia, agnosia or a disturbance 
in executive functioning. The cognitive deficits should be 
sufficiently severe to cause impairment in occupational or 
social functioning and should represent a decline from a 
previously higher level of functioning.7 Once the presence 
of dementia is established, an attempt should be made to 
identify its aetiology through its history, a thorough clinical 
examination, neuropsychological assessment and, where 
feasible, imaging and laboratory studies. None of the 
currently available biological markers, however, is useful 
for establishing the diagnosis of any of the most common 
forms of dementia with certainty: AD, vascular dementia, 
dementia with Lewy bodies and frontotemporal dementia. 
Clinicians should therefore rely on clinical criteria to make 
a diagnosis.
Assessment of dementia
Several instruments that facilitate the initial screening of 
patients suspected of being at risk of dementia exist. The 
most common instrument employed for this purpose is the 
mini-mental status examination. Despite widespread use in 
South Africa, however, its psychometric validity for the local 
population is unknown. If this initial assessment evidences 
cognitive fall-off, it is therefore recommended that further 
neuropsychological assessment of memory, language, 
visuospatial and executive functioning be facilitated via 
referral to a neurologist or neuropsychologist.
Lentegeur Hospital utilises a ‘brief’ assessment for this 
purpose. The assessment is designed to assess the 
following cognitive domains to identify patients suffering 
from dementia: attention or concentration, orientation, 
speech and language, executive planning, visuospatial 
skills, psychomotor functioning and problem-solving 
ability. Tests are selected for inclusion in the battery on the 
basis of their capacity to capture the specific diagnostic 
deficits in the nosological criteria for dementia. Table 1 
lists the neuropsychological assessment techniques that 
may be administered during the clinical interview to aid 
the diagnosis of dementia. These include the identification 
of whether patients have lost the ability for adaptive 
functioning. In other words, are they still able to carry out 
tasks encountered in daily living, such as bathing, toileting 
and grooming? It is important, however, that the assessed 
Table 1: Diagnostic features and interview assessment techniques
Diagnostic feature Assessment technique
Memory impairment Can the patient repeat a series of words or pictures, recall the information after a delay of several minutes and then 
recognise the words or pictures from a list of multiple others? Does the patient constantly lose valuables (e.g. wallets and 
keys) or forget food cooking on the stove? Can the patient remember important dates in her or his personal life? Can the 
patient sequence important events in history in the order that they occurred (e.g. the release of Nelson Mandela, World 
War 1 and the 9/11 bombing of the Twin Towers)?
Executive and cognitive 
disturbance
Can the patient draw a clock with all the numbers and set the time according to your instruction? Does the patient display 
the ability to plan and design well? Does the patient spontaneously initiate behaviour or is excessive prompting required? 
The patient’s abstract or concrete thinking style is checked by asking the meaning of a metaphor (e.g. “People in glass 
houses shouldn’t throw stones” or, in the case of patients with less exposure to formal education, “In which ways are cats 
and dogs similar?”). Can the patient count to 10, recite the alphabet or subtract serial 3s?
Deterioration of language 
function (aphasia)
Is the patient’s speech vague or empty with excessive use of terms such as “thing” or “it”? Does the patient have difficulty 
producing the names of individuals or objects and pictures? Can the patient name objects in the room (e.g. desk, lamp or 
chair) or follow commands (e.g. “Point to the door and then at the table”) and repeat phrases (e.g. “No ifs, ands or buts”)?
Impaired motor activities 
(apraxia)
Deficits in cooking, dressing or drawing may be reported. The patient is therefore asked to pantomime an activity (e.g. 
making a cup of tea or combing hair) or to execute a known motor act (e.g. waving goodbye). The patient may also be 
asked to demonstrate how to brush teeth, to assemble blocks into designs or to copy intersecting pentagons.
Impaired orientation Does the patient know what day, month and year it is? Does the patient know where she or he is (e.g. the particular 
hospital, town or country)?
Emotional, personality and 
interpersonal changes
Do family members report a change in the patient’s personality? Is she or he more volatile, aggressive, unpredictable, 
emotionally shallow or cold? Is there evidence of apathy or withdrawal?
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behaviours should be those expected of individuals at their 
particular age given their specific cultural setting. Such 
information is usually obtained by perusing the patients’ 
history or interviewing a caregiver.
Special investigations and referrals
All patients with suspected dementia should undergo 
thorough physical and neurological examinations. Medical 
illnesses that can result in dementia include thyroid disease, 
atherosclerotic-vascular disease, collagen-vascular disease 
(such as systemic lupus erythematosus) and infections. 
Clinicians should be attentive to the skin for the thinning of 
hair and eyebrows, spider hemangiomata, palmar erythema, 
malar rash or Kaposi’s sarcoma. Heart sounds, liver texture 
and size, and the presence of fever, hypertension or 
lymphadenopathy may also provide important diagnostic 
clues. Visual-field defects, eye-movement abnormalities, 
facial asymmetry, dysarthria, focal weakness and spasticity 
may indicate the presence of focal-brain or brain-stem 
lesions due to stroke, tumour or infectious disease, such 
as toxoplasmosis. Where feasible, patients with clinical-
dementia syndrome should undergo structural-brain imaging 
with non-contrast computed tomography or magnetic 
resonance imaging to evaluate for focal lesions, deep 
white-matter ischaemic changes and regions of atrophy. 
Certain laboratory tests are valuable for the initial screening 
of patients with cognitive changes. In particular, thyroid-
function tests (testing for the thyroid-stimulating hormone 
and free T4) and the checking of vitamin B
12 
levels should 
be checked in patients with cognitive complaints. In cases 
of borderline B
12 
deficiency, elevated levels of homocysteine 
and methylmalonic acid enhance the sensitivity of B
12 
levels. 
Patients with risk factors for HIV or venereal syphilis should 
undergo appropriate tests.2
Management of dementia
It is preferable that the management of dementia be 
multidisciplinary in nature. Family practitioners should 
contain and alleviate the family’s grief and anxiety by 
providing education on the patient’s diagnosis and an 
attentive and supportive space within which to voice 
concerns and fears. They will furthermore most likely be 
responsible for engaging the family in conversations around 
care-giving arrangements or possible institutionalisation 
and for coordinating referrals to other disciplines. Family 
practitioners should also bear the following in mind:
• It is preferable to delay institutionalisation as long as 
this is feasible and within the caregiver’s capacity to 
do so, since patients with dementing diseases enjoy a 
longer life expectancy when not institutionalised.
• Encourage the performance of activities of daily living 
and the provision of opportunities for cognitive exercise 
in the patient, such as reading and writing, listening 
to the radio, watching television, listening to music, 
participating in conversations with others and perhaps 
doing puzzles and playing board-games if this is 
possible.
• Refer the family to a psychologist or specialist support 
group, such as Dementia SA, for psychotherapeutic 
intervention or counselling. Such intervention is 
beneficial in improving the caregiver’s quality of life 
and greatly builds the caregiver’s psycho-emotional 
resources, increasing the likelihood of managing the 
challenges associated with caring for a patient with 
dementia.
Table 2: Classification of dementia drugs8
A. Cholinergic deficiency
1.	Pre-synaptic	agents:
• These drugs either increase the synthesis of acetylcholine 
(Ach) or promote the release of Ach:
• Ach precursors: Choline or lecithin
• Increased Ach synthesis/release: Piracetam, 
4-amino-pyridine
• Selective muscarinic 2 receptor antagonists: Gallamine, 
scopolamine
• Anti-choline esterases: Tetrahydroaminoacridine
2.	Synaptic	agents:
 These drugs limit the removal of Ach from the synapse – choline 
esterase inhibitors (CHEIs), e.g. physostigmine and metrifonate:






• Nerve growth factor gene delivery
3.		Post-synaptic	agents:
    Cholinergic agents acting directly on the muscarinic receptors:
  Pilocarpine






2.  Aß vaccination
3.  Immunotherapy – bapineuzumab and A ß peptide antibody
4.  Secretase effectors:
i) LY450139, a non-selective γ secretase inhibitor
ii) Memapsin 2 (ß secretase)
5.  Selective amyloid-lowering agents:
i) Tarenflurbil – α γ secretase modulator
ii) Non-steroidal anti-inflammatory drugs – regulate γ secretase
D. Exocitoxicity
 Glutamate toxicity to neurons:
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• Refer the patient to a neurologist to assist in the 
identification of signs of Parkinson’s disease, strokes, 
tumours and other medical conditions that may impair 
memory and thinking (such as head injuries) and of 
physical function.
• Refer the patient to a psychiatrist to exclude other 
underlying or co-morbid psychiatric disorders, such as 
depression, to determine which thinking and memory 
functions may be affected and to what degree and 
to provide ongoing management in the event that 
psychiatric symptoms have begun to emerge.
The development of the pharmacological treatment of 
dementia is problematic, as clinical improvement is not well 
understood or defined. Table 2 outlines a classification of 
all the drugs that may potentially have a clinical effect on 
patients suffering from dementia.
Of all these drugs, only the following four are registered for 





Patients with a diagnosis of AD may also require antid-
epressants (sertraline, escitalopram, trazodone), atypical 
antipsychotics (risperidone, olanzapine, quetiapine) or 
anticonvulsants (carbamazepine, valproic acid).
The following practical approach is advocated in the 
management of dementia:8
• A thorough clinical examination and special 
investigations to ascertain the type of dementia.
• The treatment of underlying conditions and other 
chronic diseases, such as hypertension and diabetes.
• The severity scoring of the dementia.
• The prescription, initially, of either a second-generation 
or an exocitotoxicity drug (memantine).
• The prescription, initially, of a low dose and the 
evaluation of side effects and tolerability in the first 
month and of efficacy over the next two months.
• If not efficacious, an increase in the dose to the 
maximum recommended dose.
• The addition of either a CHEI or memantine to the 
regimen, depending on which one was started first.
Conclusion
Dementia is a progressively degenerative disease that is 
frequently encountered in general family practice. Diagnosis 
is best made following the collection of a comprehensive 
history and a thorough clinical examination that includes 
both physical and neurological investigation. The 
assessment recommendations outlined in this article would 
be of great assistance to family practitioners in gathering a 
large amount of valuable information regarding a patient’s 
neurocognitive functioning. Multidisciplinary input from 
specialist neurology and mental-health professionals should 
also be sought to aid accurate diagnosis and the complete 
management of the illness. Finally, it is best borne in mind 
that the management of dementia should focus on both the 
identified patient and the caregiver.
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